Retinylamine benefits early diabetic retinopathy in mice

Journal of Biological Chemistry

Volumn 290, Issue 35, 2015, Pages 21568-21579

  Liu, Haitao ^a   Tang, Jie ^a   Du, Yunpeng ^a   Lee, Chieh Allen ^a   Golczak, Marcin ^a   Muthusamy, Arivalagan ^b   Antonetti, David A ^b   Veenstra, Alexander A ^a   Amengual, Jaume ^a   Von Lintig, Johannes ^a   Palczewski, Krzysztof ^a   Kern, Timothy S ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELLS; EYE PROTECTION; OPHTHALMOLOGY; OXYGEN; PROTEINS;

ACYLTRANSFERASE; DIABETIC MICE; DIABETIC RETINOPATHY; NON-DIABETIC CONTROL; RETINAL CELLS; STREPTOZOTOCIN; SUPEROXIDE GENERATION; VISUAL FUNCTIONS;

MAMMALS;

AGENTS ACTING ON THE EYE; ALBUMIN; LECITHIN RETINOL ACYLTRANSFERASE; RETINYLAMINE; SUPEROXIDE; UNCLASSIFIED DRUG; ACYLTRANSFERASE; DITERPENE; GLUCOSE; LECITHIN-RETINOL ACYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOCHEMISTRY; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; DIABETIC RETINOPATHY; DRUG EFFECT; ENDOTHELIUM CELL; EX VIVO STUDY; HISTOPATHOLOGY; IN VIVO STUDY; LEUKOCYTE; MALE; MOUSE; MOUSE MUTANT; NERVE LESION; NONHUMAN; PATHOGENESIS; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA CAPILLARY; RETINA NEUROEPITHELIAL LAYER; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VASCULAR LESION; VISION; ANIMAL; BLOOD; C57BL MOUSE; CELL SEPARATION; CHEMISTRY; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; INFLAMMATION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHOTORECEPTOR CELL; RETINA;

ACYLTRANSFERASES; ANIMALS; CELL SEPARATION; DIABETIC RETINOPATHY; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GLUCOSE; INFLAMMATION; LEUKOCYTES; MALE; MICE, INBRED C57BL; OXIDATIVE STRESS; PERMEABILITY; PHOTORECEPTOR CELLS, VERTEBRATE; RETINA; SUPEROXIDES;

EID: 84940479597     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.655555     Document Type: Article

References (81)

1. Kern, T., and Huang, S. (2010) in Ocular Disease: Mechanisms And Management (Levin, L., and Albert, D., eds) pp. 506-513, Saunders Elsevier, Inc., Philadelphia
2. Lovasik, J. V., and Spafford, M. M. (1988) An electrophysiological investigation of visual function in juvenile insulin-dependent diabetes mellitus. Am. J. Optom. Physiol. Opt. 65, 236-253
3. Brinchmann-Hansen, O., Bangstad, H. J., Hultgren, S., Fletcher, R., Dahl-Jørgensen, K., Hanssen, K. F., and Sandvik, L. (1993) Psychophysical visual function, retinopathy, and glycemic control in insulin-dependent diabetics with normal visual acuity. Acta Ophthalmol. 71, 230-237
4. Banford, D., North, R. V., Dolben, J., Butler, G., and Owens, D. R. (1994) Longitudinal study of visual functions in young insulin dependent diabetics. Ophthalmic Physiol. Opt. 14, 339-346
5. Jackson, G. R., Scott, I. U., Quillen, D. A., Walter, L. E., and Gardner, T. W. (2012) Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy. Br. J. Ophthalmol. 96, 699-703
6. Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., and Gardner, T. W. (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Investig. 102, 783-791
7. Martin, P. M., Roon, P., Van Ells, T. K., Ganapathy, V., and Smith, S. B. (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Vis. Sci. 45, 3330-3336
8. Kern, T. S., and Barber, A. J. (2008) Retinal ganglion cells in diabetes. J. Physiol. 586, 4401-4408
9. Du, Y., Cramer, M., Lee, C. A., Tang, J., Muthusamy, A., Antonetti, D. A., Jin, H., Palczewski, K., and Kern, T. S. (2015) Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability. FASEB J. 29, 2194-2204
10. Lee, C. A., Li, G., Patel, M. D., Petrash, J. M., Benetz, B. A., Veenstra, A., Amengual, J., von Lintig, J., Burant, C. J., Tang, J., and Kern, T. S. (2014) Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, RAGE, leukocytes, and aldose reductase. Invest. Ophthalmol. Vis. Sci. 55, 2904-2910
11. Kowluru, R. A., Tang, J., and Kern, T. S. (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50, 1938-1942
12. Kanwar, M., Chan, P. S., Kern, T. S., and Kowluru, R. A. (2007) Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci. 48, 3805-3811
13. Berkowitz, B. A., Gradianu, M., Bissig, D., Kern, T. S., and Roberts, R. (2009) Retinal ion regulation in a mouse model of diabetic retinopathy: natural history and the effect of Cu/Zn superoxide dismutase overexpression. Invest. Ophthalmol. Vis. Sci. 50, 2351-2358
14. Tang, J., and Kern, T. S. (2011) Inflammation in diabetic retinopathy. Prog. Retin. Eye Res. 30, 343-358
15. de Gooyer, T. E., Stevenson, K. A., Humphries, P., Simpson, D. A., Gardiner, T. A., and Stitt, A. W. (2006) Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest. Ophthalmol. Vis. Sci. 47, 5561-5568
16. Arden, G. B., and Sivaprasad, S. (2012) The pathogenesis of early retinal changes of diabetic retinopathy. Doc. Ophthalmol. 124, 15-26
17. Du, Y., Veenstra, A., Palczewski, K., and Kern, T. S. (2013) Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc. Natl. Acad. Sci. U.S.A. 110, 16586-16591
18. Zhang, J., Dong, Z., Mundla, S. R., Hu, X. E., Seibel, W., Papoian, R., Palczewski, K., and Golczak, M. (2015) Expansion of first-in-class drug candidates that sequester toxic all-trans-retinal and prevent light-induced retinal degeneration. Mol. Pharmacol. 87, 477-491
19. Golczak, M., Kuksa, V., Maeda, T., Moise, A. R., and Palczewski, K. (2005) Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle. Proc. Natl. Acad. Sci. U.S.A. 102, 8162-8167
20. Maeda, A., Maeda, T., Golczak, M., and Palczewski, K. (2008) Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol. Chem. 283, 26684-26693
21. Golczak, M., Imanishi, Y., Kuksa, V., Maeda, T., Kubota, R., and Palczewski, K. (2005) Lecithin:retinol acyltransferase is responsible for amidation of retinylamine, a potent inhibitor of the retinoid cycle. J. Biol. Chem. 280, 42263-42273
22. Saari, J. C., and Bredberg, D. L. (1989) Lecithin:retinol acyltransferase in retinal pigment epithelial microsomes. J. Biol. Chem. 264, 8636-8640
23. Randolph, R. K., and Ross, A. C. (1991) Vitamin A status regulates hepatic lecithin:retinol acyltransferase activity in rats. J. Biol. Chem. 266, 16453-16457
24. Schmitt, M. C., and Ong, D. E. (1993) Expression of cellular retinol-binding protein and lecithin-retinol acyltransferase in developing rat testis. Biol. Reprod. 49, 972-979
25. Zolfaghari, R., and Ross, A. C. (2002) Lecithin:retinol acyltransferase expression is regulated by dietary vitamin A and exogenous retinoic acid in the lung of adult rats. J. Nutr. 132, 1160-1164
26. Kashyap, V., Laursen, K. B., Brenet, F., Viale, A. J., Scandura, J. M., and Gudas, L. J. (2013) RARγ is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells. J. Cell Sci. 126, 999-1008
27. Zolfaghari, R., Wang, Y., Chen, Q., Sancher, A., and Ross, A. C. (2002) Cloning and molecular expression analysis of large and small lecithin: retinol acyltransferase mRNAs in the liver and other tissues of adult rats. Biochem. J. 368, 621-631
28. Maeda, A., Maeda, T., Golczak, M., Imanishi, Y., Leahy, P., Kubota, R., and Palczewski, K. (2006) Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice. Mol. Pharmacol. 70, 1220-1229
29. Puntel, A., Maeda, A., Golczak, M., Gao, S. Q., Yu, G., Palczewski, K., and Lu, Z. R. (2015) Prolonged prevention of retinal degeneration with retinylamine loaded nanoparticles. Biomaterials 44, 103-110
30. Batten, M. L., Imanishi, Y., Maeda, T., Tu, D. C., Moise, A. R., Bronson, D., Possin, D., Van Gelder, R. N., Baehr, W., and Palczewski, K. (2004) Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J. Biol. Chem. 279, 10422-10432
31. Sakami, S., Maeda, T., Bereta, G., Okano, K., Golczak, M., Sumaroka, A., Roman, A. J., Cideciyan, A. V., Jacobson, S. G., and Palczewski, K. (2011) Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J. Biol. Chem. 286, 10551-10567
32. Tang, J., Allen Lee, C., Du, Y., Sun, Y., Pearlman, E., Sheibani, N., and Kern, T. S. (2013) MyD88-dependent pathways in leukocytes affect the retina in diabetes. PLoS One 8, e68871
33. Du, Y., Tang, J., Li, G., Berti-Mattera, L., Lee, C. A., Bartkowski, D., Gale, D., Monahan, J., Niesman, M. R., Alton, G., and Kern, T. S. (2010) Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest. Ophthalmol. Vis. Sci. 51, 2158-2164
34. Kern, T. S., Du, Y., Miller, C. M., Hatala, D. A., and Levin, L. A. (2010) Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am. J. Pathol. 176, 2550-2558
35. Gubitosi-Klug, R. A., Talahalli, R., Du, Y., Nadler, J. L., and Kern, T. S. (2008) 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 57, 1387-1393
36. Kern, T. S., Miller, C. M., Du, Y., Zheng, L., Mohr, S., Ball, S. L., Kim, M., Jamison, J. A., and Bingaman, D. P. (2007) Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56, 373-379
37. Du, Y., Miller, C. M., and Kern, T. S. (2003) Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic. Biol. Med. 35, 1491-1499
38. Antonetti, D. A., Barber, A. J., Khin, S., Lieth, E., Tarbell, J. M., and Gardner, T. W. (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47, 1953-1959
39. Veenstra, A. A., Tang, J., and Kern, T. S. (2013) Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy. PLoS One 8, e78405
40. Talahalli, R., Zarini, S., Tang, J., Li, G., Murphy, R., Kern, T. S., and Gubitosi-Klug, R. A. (2013) Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes. J. Leukoc. Biol. 93, 135-143
41. Li, G., Veenstra, A. A., Talahalli, R. R., Wang, X., Gubitosi-Klug, R. A., Sheibani, N., and Kern, T. S. (2012) Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice. Diabetes 61, 3294-3303
42. Su, X., Sorenson, C. M., and Sheibani, N. (2003) Isolation and characterization of murine retinal endothelial cells. Mol. Vis. 9, 171-178
43. Prusky, G. T., Alam, N. M., Beekman, S., and Douglas, R. M. (2004) Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest. Ophthalmol. Vis. Sci. 45, 4611-4616
44. Liu, H., Tang, J., Lee, C. A., and Kern, T. S. (2015) Metanx and early stages of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 56, 647-653
45. Ruiz, A., Winston, A., Lim, Y. H., Gilbert, B. A., Rando, R. R., and Bok, D. (1999) Molecular and biochemical characterization of lecithin retinol acyltransferase. J. Biol. Chem. 274, 3834-3841
46. Tian, P., Ge, H., Liu, H., Kern, T. S., Du, L., Guan, L., Su, S., and Liu, P. (2013) Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine. Mol. Vis. 19, 2092-2105
47. Maeda, T., Maeda, A., Matosky, M., Okano, K., Roos, S., Tang, J., and Palczewski, K. (2009) Evaluation of potential therapies for a mouse model of human age-related macular degeneration caused by delayed all-transretinal clearance. Invest. Ophthalmol. Vis. Sci. 50, 4917-4925
48. Maeda, A., Maeda, T., and Palczewski, K. (2006) Improvement in rod and cone function in mouse model of fundus albipunctatus after pharmacologic treatment with 9-cis-retinal. Invest. Ophthalmol. Vis. Sci. 47, 4540-4546
49. Imanishi, Y., Batten, M. L., Piston, D. W., Baehr, W., and Palczewski, K. (2004) Noninvasive two-photon imaging reveals retinyl ester storage structures in the eye. J. Cell Biol. 164, 373-383
50. Chen, Y., Okano, K., Maeda, T., Chauhan, V., Golczak, M., Maeda, A., and Palczewski, K. (2012) Mechanism of all-trans-retinal toxicity with implications for Stargardt disease and age-related macular degeneration. J. Biol. Chem. 287, 5059-5069
51. Maeda, A., Golczak, M., Chen, Y., Okano, K., Kohno, H., Shiose, S., Ishikawa, K., Harte, W., Palczewska, G., Maeda, T., and Palczewski, K. (2012) Primary amines protect against retinal degeneration in mouse models of retinopathies. Nat. Chem. Biol. 8, 170-178
52. Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., Kern, T. S., and Adamis, A. P. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18, 1450-1452
53. Adamis, A. P., and Berman, A. J. (2008) Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin. Immunopathol. 30, 65-84
54. Zheng, L., and Kern, T. (2009) Role of nitric oxide, superoxide, peroxynitrite and poly(ADP-ribose) polymerase in diabetic retinopathy. Front. Biosci. 14, 3974-3987
55. Kaul, K., Hodgkinson, A., Tarr, J. M., Kohner, E. M., and Chibber, R. (2010) Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Curr. Diabetes Rev. 6, 294-303
56. Redmond, T. M., Poliakov, E., Yu, S., Tsai, J. Y., Lu, Z., and Gentleman, S. (2005) Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc. Natl. Acad. Sci. U.S.A. 102, 13658-13663
57. Jin, M., Li, S., Moghrabi, W. N., Sun, H., and Travis, G. H. (2005) Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 122, 449-459
58. Berkowitz, B. A., Gorgis, J., Patel, A., Baameur, F., Gurevich, V. V., Craft, C. M., Kefalov, V. J., and Roberts, R. (2015) Development of an MRI biomarker sensitive to tetrameric visual arrestin 1 and its reduction via light-evoked translocation in vivo. FASEB J. 29, 554-564
59. Berkowitz, B. A., Roberts, R., Oleske, D. A., Chang, M., Schafer, S., Bissig, D., and Gradianu, M. (2009) Quantitative mapping of ion channel regulation by visual cycle activity in rodent photoreceptors in vivo. Invest. Ophthalmol. Vis. Sci. 50, 1880-1885
60. Okawa, H., Sampath, A. P., Laughlin, S. B., and Fain, G. L. (2008) ATP consumption by mammalian rod photoreceptors in darkness and in light. Curr. Biol. 18, 1917-1921
61. Fan, J., Rohrer, B., Frederick, J. M., Baehr, W., and Crouch, R. K. (2008) Rpe65-/- and Lrat-/- mice: comparable models of Leber congenital amaurosis. Invest. Ophthalmol. Vis. Sci. 49, 2384-2389
62. Talahalli, R., Zarini, S., Sheibani, N., Murphy, R. C., and Gubitosi-Klug, R. A. (2010) Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 1699-1708
63. Golden, J. B., McCormick, T. S., and Ward, N. L. (2013) IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities. Cytokine 62, 195-201
64. Wang, Y., Gao, H., Loyd, C. M., Fu, W., Diaconu, D., Liu, S., Cooper, K. D., McCormick, T. S., Simon, D. I., and Ward, N. L. (2012) Chronic skin-specific inflammation promotes vascular inflammation and thrombosis. J. Invest. Dermatol. 132, 2067-2075
65. Hammes, H.-P., Martin, S., Federlin, K., Geisen, K., and Brownlee, M. (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. U.S.A. 88, 11555-11558
66. Hammes, H.-P., Brownlee, M., Edelstein, D., Saleck, M., Martin, S., and Federlin, K. (1994) Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 37, 32-35
67. Hammes, H. P., Strödter, D., Weiss, A., Bretzel, R. G., Federlin, K., and Brownlee, M. (1995) Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in rat model. Diabetologia 38, 656-660
68. Kern, T. S., Tang, J., Mizutani, M., Kowluru, R. A., Nagaraj, R. H., Romeo, G., Podesta, F., and Lorenzi, M. (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest. Ophthalmol. Vis. Sci. 41, 3972-3978
69. Kowluru, R. A., Engerman, R. L., and Kern, T. S. (2000) Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr. Eye Res. 21, 814-819
70. Kern, T. S., and Engerman, R. L. (2001) Pharmacologic inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50, 1636-1642
71. Zheng, L., Gong, B., Hatala, D. A., and Kern, T. S. (2007) Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest. Ophthalmol. Vis. Sci. 48, 361-367
72. Thornalley, P. J., Yurek-George, A., and Argirov, O. K. (2000) Kinetics and mechanism of the reaction of aminoguanidine with the α-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol. 60, 55-65
73. Thornalley, P. J. (2003) Use of aminoguanidine (pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 419, 31-40
74. Reddy, V. P., and Beyaz, A. (2006) Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov. Today 11, 646-654
75. Viberti, G., Slama, G., Pozza, G., Czyzyk, A., Bilous, R. W., Gries, A., Keen, H., Fuller, J. H., and Menzinger, G. (1997) Early closure of European pimagedine trial. Steering Committee. Safety Committee. Lancet 350, 214-215
76. Mizutani, M., Gerhardinger, C., and Lorenzi, M. (1998) Muller cell changes in human diabetic retinopathy. Diabetes 47, 445-449
77. Rungger-Brändle, E., Dosso, A. A., and Leuenberger, P. M. (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 41, 1971-1980
78. Zeng, X. X., Ng, Y. K., and Ling, E. A. (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis. Neurosci. 17, 463-471
79. Puro, D. G. (2002) Diabetes-induced dysfunction of retinal Müller cells. Trans. Am. Ophthalmol. Soc. 100, 339-352
80. Du, Y., Sarthy, V. P., and Kern, T. S. (2004) Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R735-R741
81. Fletcher, E. L., Phipps, J. A., Ward, M. M., Puthussery, T., and Wilkinson-Berka, J. L. (2007) Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr. Pharm. Des. 13, 2699-2712